Oxaliplatin Completed Phase 2 Trials for Non-Small Cell Lung Carcinoma (NSCLC) Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT01243775BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC
NCT01222312Study for Therapy of Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) With Cisplatin / Docetaxel or Oxaliplatin / Docetaxel
NCT00356122Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)
NCT00271271Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients
NCT00251524A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC
NCT00217282Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer
NCT00240097Study of Sequential Topoisomerase, Irinotecan/Oxaliplatin - Etoposide /Carboplatin in Extensive Small Cell Lung Cancer (SCLC)
NCT00406302Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)